These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 3240225
1. Biological characterization of recombinant human erythropoietin. Krumwieh D, Arnold I, Seiler FR. Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225 [Abstract] [Full Text] [Related]
2. Comparison of relevant biological assays for the determination of biological active erythropoietin. Krumwieh D, Arnold I, Seiler FR. Dev Biol Stand; 1988 Aug; 69():15-22. PubMed ID: 3224764 [Abstract] [Full Text] [Related]
3. Characterization and biological effects of recombinant human erythropoietin. Egrie JC, Strickland TW, Lane J, Aoki K, Cohen AM, Smalling R, Trail G, Lin FK, Browne JK, Hines DK. Immunobiology; 1986 Sep; 172(3-5):213-24. PubMed ID: 3542810 [Abstract] [Full Text] [Related]
4. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W. Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [Abstract] [Full Text] [Related]
5. Evaluation of indicators of erythropoiesis stimulated by recombinant human erythropoietin in renal anemia. Schmidt G, Stamminger G, Daniel A, Gross J, Syllm-Rapoport I, Lun A, Zoellner K. Biomed Biochim Acta; 1990 Aug; 49(2-3):S275-9. PubMed ID: 2386517 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of erythropoietin in genetically anemic mice. Kato M, Miura K, Kamiyama H, Okazaki A, Kumaki K, Kato Y, Sugiyama Y. Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298 [Abstract] [Full Text] [Related]
7. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide]. Aguirre MV, Juaristi JA, Alba Alvarez M, Carmuega RJ, Brandan NC. Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578 [Abstract] [Full Text] [Related]
8. [Effects erythropoietin on experimental anemia in rats with chronic renal failure]. Ling SS, Zhou Y, Sun WL, Zhu DC, Zhang HY, Tang GZ, Jin YF, Zhu JZ. Yao Xue Xue Bao; 1992 Jun; 27(6):412-7. PubMed ID: 1442067 [Abstract] [Full Text] [Related]
9. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia. Fujita Y, Inoue S, Horiguchi S, Kuki A. Miner Electrolyte Metab; 1995 Jun; 21(1-3):50-4. PubMed ID: 7565462 [Abstract] [Full Text] [Related]
10. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. Hamamori Y, Samal B, Tian J, Kedes L. J Clin Invest; 1995 Apr; 95(4):1808-13. PubMed ID: 7706487 [Abstract] [Full Text] [Related]
11. Effect of recombinant human erythropoietin on anemia caused by a murine mammary carcinoma. Mac Manus MP, Elder GE, Abram WP, Bridges JM. Exp Hematol; 1990 Aug; 18(7):848-52. PubMed ID: 2379551 [Abstract] [Full Text] [Related]
12. Thrombopoietic factor enhances murine megakaryopoiesis induced by recombinant erythropoietin. Nagasawa T, Satoh K, Abe T. Int J Hematol; 1991 Apr; 54(2):159-64. PubMed ID: 1747449 [Abstract] [Full Text] [Related]
13. Erythropoietin enhances immune responses in mice. Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D. Eur J Immunol; 2007 Jun; 37(6):1584-93. PubMed ID: 17458859 [Abstract] [Full Text] [Related]
14. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats. Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A. Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912 [Abstract] [Full Text] [Related]
15. Effect of chronic renal failure on the expression of erythropoietin message in a murine model. Zhang F, Laneuville P, Gagnon RF, Morin B, Brox AG. Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229 [Abstract] [Full Text] [Related]
16. Impaired response of polycythemic mice to erythropoietin induced by protein starvation imposed after hormone administration. Barceló AC, Alippi RM, Boyer P, Olivera MI, Mide SM, Caro J, Bozzini CE. Stem Cells; 1993 Jul; 11(4):296-302. PubMed ID: 8401252 [Abstract] [Full Text] [Related]
17. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. Eliopoulos N, Gagnon RF, Francois M, Galipeau J. J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321 [Abstract] [Full Text] [Related]
18. A mouse model for an erythropoietin-deficiency anemia. Zeigler BM, Vajdos J, Qin W, Loverro L, Niss K. Dis Model Mech; 2010 Jun; 3(11-12):763-72. PubMed ID: 20959632 [Abstract] [Full Text] [Related]
19. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice. Yoshimi M, Maeyama T, Yamada M, Hamada N, Fukumoto J, Kawaguchi T, Kuwano K, Nakanishi Y. Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087 [Abstract] [Full Text] [Related]
20. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients. Schaefer RM, Schaefer L, Heidland A. Przegl Lek; 1992 Sep; 49(1-2):41-2. PubMed ID: 1455005 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]